WIM
BMRN icon

Westside Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Westside Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.5K Hold
760
– – 0.01% 643
2026
Q1 		$42.9K Hold
760
– – 0.01% 615
2025
Q4 		$45.2K Hold
760
– – 0.01% 572
2025
Q3 		$41.2K Sell
760
-400
-34% -$22.9K 0.01% 610
2025
Q2 		$63.8K Hold
1,160
– – 0.01% 419
2025
Q1 		$82K Sell
1,160
-150
-11% -$10.1K 0.02% 336
2024
Q4 		$86.1K Hold
1,310
– – 0.02% 325
2024
Q3 		$92.1K Buy
1,310
+100
+8% +$8.36K 0.02% 322
2024
Q2 		$99.6K Hold
1,210
– – 0.02% 308
2024
Q1 		$106K Hold
1,210
– – 0.03% 287
2023
Q4 		$117K Hold
1,210
– – 0.03% 261
2023
Q3 		$107K Hold
1,210
– – 0.03% 265
2023
Q2 		$105K Sell
1,210
-600
-33% -$56.5K 0.03% 267
2023
Q1 		$176K Sell
1,810
-400
-18% -$41.5K 0.05% 220
2022
Q4 		$228 Sell
2,210
-160
-7% -$15K ﹤0.01% 314
2022
Q3 		$6.97K Sell
2,370
-1,550
-40% -$138K 0.02% 213
2022
Q2 		$6.66K Hold
3,920
– – 0.02% 207
2022
Q1 		$6.64K Hold
3,920
– – 0.01% 208
2021
Q4 		$6.51K Sell
3,920
-800
-17% -$66K 0.01% 200
2021
Q3 		$6.53K Buy
4,720
+200
+4% +$15.8K 0.02% 202
2021
Q2 		$7.04K Buy
4,520
+650
+17% +$51.5K 0.02% 194
2021
Q1 		$6.33K Buy
3,870
+3,510
+975% +$287K 0.02% 189
2020
Q4 		$31 Buy
+360
New +$28.5K ﹤0.01% 382

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Westside Investment Management's BMRN Position: Q2 2026 in Review

Westside Investment Management held its BioMarin Pharmaceuticals (BMRN) position steady in Q2 2026 at 760 shares worth $43.5K. The position accounts for 0.01% of the portfolio, ranked #643.

Westside Investment Management first reported a position in BMRN in Q4 2020 and has held it in 23 quarters since. The position peaked at $176K in Q1 2023. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Westside Investment Management held 760 shares of BioMarin Pharmaceuticals worth $43.5K as of Q2 2026.
  • Westside Investment Management left its BioMarin Pharmaceuticals share count unchanged in Q2 2026.
  • BioMarin Pharmaceuticals made up 0.01% of Westside Investment Management's portfolio in Q2 2026, its #643 holding.
  • Westside Investment Management first reported a position in BioMarin Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Westside Investment Management's BioMarin Pharmaceuticals position peaked at $176K in Q1 2023.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.